chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The night of the vaccination I had severe flu-like symptoms like sweating, aches,  and nausea. These went away after a day. Over the months following my vaccination, I experienced increasing palpitations and I eventually had a handful of SVT's that sent me to the ER. One morning, after having consumed alcohol the night before, I had a racing heart and shortness of breath and took a breath from an inhaler and went tachycardic. The ER doctors thought that nothing was wrong with me. After testing I was found to have developed heart failure seemingly inexplicably. Two years later I am much better after taking beta blockers but I am still recovering and I will be dealing with this illness for the foreseeable future.
Patient was positive for COVID-19 in July 2021 and reported symptoms of tingling of the extremities, chills, fever, fatigue, and headaches.  Patient received her first dose of the COVID-19 Moderna vaccine on October 29, 2021 at 3:50 PM.  Later that evening, she reported  stiffness of the hands and heaviness of the legs. As of today, she is still experiencing stiffness and heaviness in the extremities in addition to fatigue and headaches.
Sore arm; A spontaneous report was received from a consumer (patient), concerning a 67-years-old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced sore arm (pain in arm).  The patient's medical history was not provided.  Concomitant medications included omeprazole, fluoxetine hydrochloride, propranolol, colestipol, acetylsalicylic acid, and calcium.  On 28 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot number: 037K20A) intramuscularly for prophylaxis of COVID-19 infection.  On 28 Dec 2020, following the first vaccination, the patient experienced sore arm for a couple of days.  Treatment information for the event was not provided.  There was no change planned to the dosing schedule of mRNA-1273 in response to the event.  The outcome of the event of sore arm (pain in arm) was resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
redness, tenderness rt upper arm toward front dx allerg rxn to vaccine vs cellulitis secondary to IVDU (last 19JAN);
HEADACHE; This spontaneous report received from a patient concerned a 33 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 11:00 in left arm for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021 14:00, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache. This report was non-serious.
p/vax pt c/o lt deltoid induration that increased in size & warmth;on overt systemic sx;non specific myositis;
pt devel fever upt to 102 & swollen arm around inject site by 24 hrs post vax; fever managed w/APAP; MD saw pt @ about 24 hrs post vax & dx cellulitis, gave ATB for infection;
Vaqta and Gardasil administered in left deltoid without incident. Bexsero administered in right deltoid.  Immediately patient stated he didn't feel well, approximately 5 seconds later his eyes rolled up, he stiffened. Nurse attempted to restrain patient in chair, but patient jerked very hard away from nurse, fell out of chair, hitting face and chin on wall.  Fell face down. Appeared to have lost consciousness for approximately five seconds. Did not respond to verbal commands. Rolled to back by nurse. Quickly began speaking. Patient sustained small abrasions to lip and tip of nose. A larger cut, approximately 2.5 inches below chin, open. Area cleaned and ice applied. No other abrasions or cuts identified. Able to move all extremities. He may have chipped a tooth. He complained of left jaw pain but denied headache. Patient denied prior history of fainting or problems with vaccinations. Mother contacted and came to health department.
An unspecified Nurse cut her hand on an unspecified finger on the date of 8/21/2019 and it was bleeding after the GARDASIL 9 syringe broke while giving an injection to a patient; An unspecified Nurse cut her hand on an unspecified finger on the date of 8/21/2019 and it was bleeding after the GARDASIL 9 syringe broke while giving an injection to a patient; An unspecified Nurse cut her hand on an unspecified finger on the date of 8/21/2019 and it was bleeding after the GARDASIL 9 syringe broke while giving an injection to a patient; An unspecified Nurse cut her hand on an unspecified finger on the date of 8/21/2019 and it was bleeding after the GARDASIL 9 syringe broke while giving an injection to a patient; An unspecified Nurse cut her hand on an unspecified finger on the date of 8/21/2019 and it was bleeding after the GARDASIL 9 syringe broke while giving an injection to a patient; An unspecified Nurse cut her hand on an unspecified finger on the date of 8/21/2019 and it was bleeding after the GARDASIL 9 syringe broke while giving an injection to a patient; This spontaneous report was received from a field representative refers to a female patient (unspecified nurse) of unknown age. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were unknown by the reporter. On 21-AUG-2019, the patient cut her hand on an unspecified finger and it was bleeding after the syringe broke while giving hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (lot # R020948, expiry date was not reported (upon internal validation expiry date was validated as 04-MAY-2021) to a patient for prophylaxis (wound, product quality issue, exposure via skin contact, occupational exposure to product, accidental exposure to product and wound haemorrhage). The field representative reports that the patient, whom she was injecting did not have any adverse events and that the patient received the correct dosage of the vaccine. The nurse was treated by an unspecified physician and the treatment received was as follows: Superglue for the cut of the unknown finger". As 26-AUG-2019, the nurse was seeking treatment at employee health today. In addition the administrator stated that it was a vaccine pre-filled syringe was discarded and thrown away in the sharp container. Administrator stated that they took a photo of the syringe and will email the photo along with the case number. Administrator answered some of the product quality questions and then abruptly hung up as she had a conference call. The outcome of wound, exposure via skin contact, occupational exposure to product, accidental exposure to product, product quality issue and wound haemorrhage was unknown at the time of report. The causality assessment of the events product quality issue, wound haemorrhage and wound with respect to hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) was not reported.
Patient received what was believed to be a second dose of COVID-19 vaccine. However, it was discovered he received two does prior; therefore received 4 doses in total. He was assessed by the primary provider. No medical complaints at this time.
A report has been received from a Health Professional concerning a patient, Male subject, who had been receiving Nasal FLUMIST. FLUMIST started on an unknown date. The patient experienced tested positive for Flu A. The outcome of the event of tested positive for Flu A is unknown. The report was considered to be non-serious.
Initially, I had the expected symptoms (fever, chills, and nausea). I experienced dizziness for a week after the shot. I?m the beginning of June, I began having nerve pain in my left leg. I am experiencing continued numbness and pain in my left left.
Left sided sudden sensorineural hearing loss - seen at ENT specialist 5/21/21, confirmed with audiogram and treated with steroid course. At 2 weeks, the hearing has recovered to his baseline.
On 10/26/2022 at 0845 the patient above received a dose of Moderna Monovalent vaccine instead of the intended dose of Moderna Bivalent Vaccine. He received a .5 ml dose. He waited 15 minutes in our office lobby after injection with no side affects or reactions.
Redness , Rash and itching started in right side below chest in stomach area , spread  to left side, neck front and back and center of the  back spinal chord .
The 11th: headache, nausea  The 12th: Fever 101F, Joint pain, Headache, sharp kidney pain, nausea.  The 13th: hot flashes, fever 99F, kidney pain.
I had low grade fever of 100.7- 101, body aches, head congestion, and running nose. I to the urgent care and they tested me for COVID-19 and, I was positive. They prescribed me PAXLOVID 150 mg and 100 mg. I tested negative for COVID-19 on 12/25/2022.
The patient presented to the hospital with chief complaint of breakthrough seizure. Incidentally found to be COVID-19 positive on swab 12/16/21. Respiratory status has remained stable on room air and patient remains asymptomatic. Breakthrough seizure likely secondary to decreased threshold r/t active COVID-19 infection + UTI + subtherapeutic Tegretol level. Head CT negative for acute process. Loaded with 1 gram IV Keppra with neurology recommendations to maintain Tegretol 400 mg BID and Keppra 500 mg BID for maintenance. Completed 5 day course of IV Rocephin for UTI. Medically stable for discharge return to ECF WBA. No acute hospital related complications.
grandma states had 103 temp & fretful 1 hr p/immun called MD given DPH & APAP w/warm soaks to leg;
redness at injection site for over 5 days, soreness/pain at injection site for over five days, and injection site is warmer to the touch than the rest of the arm.
Pregnancy miscarriage -- 3.5 weeks pregnant at the time of vaccination and experienced a miscarriage one week later (at 4.5 weeks pregnant)
Pt received 1st dose of covid vaccine at mass clinic via curbside. Pt was given 30 minute observation due to past hx of allergic reaction to penicillin. At the end of observation period, pt reports feeling light-headed and upon observation of pt, was exhibiting facial flushing. EMS was called for evaluation. Vital signs were as follows: BP 130/86, pulse 62, SPO2 96% and RR 15. Pt declined transportation to ER. Pt instructed to proceed to nearest ER if symptoms worsen.
really didn't feel good at all; developed welts; big red patch that was hot and very tender, sore at the site; a big red patch that was hot and very tender, sore at the site; big red patch that was hot and very tender, sore at the site; exhausted; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MALAISE (really didn't feel good at all), URTICARIA (developed welts), VACCINATION SITE WARMTH (big red patch that was hot and very tender, sore at the site), VACCINATION SITE ERYTHEMA (a big red patch that was hot and very tender, sore at the site) and VACCINATION SITE PAIN (big red patch that was hot and very tender, sore at the site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Chronic fatigue (took 2 years to recover from.). Concurrent medical conditions included Immune system disorder (about 20 years ago, her immune system went hay wire, she had a high T-cell count). Concomitant products included FLUOXETINE HYDROCHLORIDE (PROZAC), BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) and THYROID (ARMOUR THYROID) for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced MALAISE (really didn't feel good at all), URTICARIA (developed welts), VACCINATION SITE WARMTH (big red patch that was hot and very tender, sore at the site), VACCINATION SITE ERYTHEMA (a big red patch that was hot and very tender, sore at the site), VACCINATION SITE PAIN (big red patch that was hot and very tender, sore at the site) and FATIGUE (exhausted). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Vaccination site erythema, Vaccination site warmth and Vaccination site pain, at an unspecified dose and frequency and DEXAMETHASONE at an unspecified dose and frequency. At the time of the report, MALAISE (really didn't feel good at all), URTICARIA (developed welts), VACCINATION SITE WARMTH (big red patch that was hot and very tender, sore at the site), VACCINATION SITE ERYTHEMA (a big red patch that was hot and very tender, sore at the site), VACCINATION SITE PAIN (big red patch that was hot and very tender, sore at the site) and FATIGUE (exhausted) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient used ice pack on a big red patch that was hot and very tender, sore at the site.
This is a spontaneous report from a contactable medical assistant communicated to a Pfizer sales representative, and from a contactable nurse on behalf of a physician. The medical assistant reported similar events for 3 patients. This is the first of three reports. A 17-18 year-old female patient of an unspecified ethnicity received TRUMENBA (Lot L13514; Expiration date 31Jul2016), first dose on 21Jun2016 11:06 AM, intramuscular in left deltoid at 0.5 ml, single for immunisation. The patient was vaccinated at private physician's office. The patient medical history and concomitant medications were not reported. The patient past drug history included allergy to Bactrim on 05Feb2012. The patient experienced swelling and pain in Aug2016. The patient visited physician. She was not admitted to hospital. The nurse considered there was a reasonable possibility that the events were related to meningococcal group b rlp2086. The outcome of the events was recovered. Follow-up (19Sep2016): New information from a contactable nurse on behalf of a physician included vaccine Lot number and Expiration date, vaccine dose administered, route of administration, site of vaccination, past drug history, causality assessment, outcome of the events. Follow-up attempts are completed. No further information is expected. Sender's Comments: Linked Report(s): US-PFIZER INC-2016383050 similar report from same reporter; US-PFIZER INC-2016383100 similar report from same reporter.
LEFT ARM WAS EXTREMELY SORE. BODY ACHES ALL OVER, LOW GRADE FEVER, NO APPETITE, FATIGUE FOR 24 HOURS,
Pt recvd Hep B vax & exp an unspecified allergic rxn; No further details were provided;
Rash (raised round red bumps) on trunk and back. Left Lower arm white bumps. Rash waxes and wanes. Feels hot. Not very itchy. No doctor visit (yet). Will do so if worsens.
Aches & Pains, chills & sweating, extreme fatigue, felt like I had been run over by a truck!  Symptoms lasted three+ days.
Muscle ache right arm; stomach ache; loss of appetite; Headache; A spontaneous report was received from a Consumer concerning herself, 76 years- old male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the events, muscle ache right arm, stomachache, loss of appetite, and headache, .  No patient's medical history was reported.   The relevant concomitant medications included losartan for hypertension, and paroxetine hydrochloride for depression.  On 02 Mar 2021, prior to the onset of the events, the patient received their second of the two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly in right arm for prophylaxis of COVID-19 infection.  On 03 Jan 2021, with onset latency of two days, the patient developed headache, which is getting worse. Moreover, the patient experienced, muscle ache, mild upset stomach, and did not have appetite.  No Laboratory investigations were provided.  No Treatment information was provided.  Action taken with mRNA-1273 in response to the events was unknown.   At the time of this report, the outcome of the events, Muscle ache right arm, stomachache, loss of appetite, and Headache,  was unknown.
Patient received QUADRACEL, MMRV and FLUZONE Flu vaccine on 9/17/2018.  On 9/18/18, Mom noticed on his right thigh where he received the QUADRACEL vaccine (Dtap/IPV), that the area was slightly red and itchy. Seen 9/19/18 and had some redness to the site and slightly itchy. No pain, no fever, or limping.
Patient turned pale, fainted, no fever or other symptoms, felt better after a little time, went get IV fluids. Patient fine. First time reaction to vaccines.
Headache, Myalgia, NauseaVomiting, hot flashes Narrative:   Other Relevant History:
1320 Pt noted onset of facial and chin numbness and tingling, progressing down L arm.  Did not notify staff.  Staff notified 1345 of L arm numbness and tingling. On additional questioning admitted to Chin pain/chin tingling. NP with patient @ 1410. 25 mg Benadryl PO at 1411; EMS w patient  . 12 lead EKG- bradycardia - sinus rate/ 50-57.  Initial BP 170/95/55/ O2 sats 100 on RA. Numbness/tingling gone @ 1425.  VSS. BP now 136/84; HR 51. Discharged home @ 1430. Patient noted that she exercised regularly and has done so for many years.
5 hours screaming unrelenting 1-3 hours post vaccine: injection site not inflammed nor edematous, not tender beyond expectaiton.
Per patient, every since he recieved his vaccination he's been getting left arm pain that goes from his shoulder down to his fingers, and nausea. He's tried Tylenol to relieve the pain, but it just comes back when the Tylenol wares off. This can be a common side effect for the vaccine, but it's been nearly 5 days and he's still feeling these side effects.
mom reported a red, firm area @ site of vax on rt thigh taking APAP; has not happended w/other immun; advised cont APAP & apply cold to are;
Swelling, redness, warm to touch, and pain at the injection site. Applied ice pack. Still prominent at 22:00 on 04/23.
Pt recv vax on 1/29/99; on 2/11/99 pt exp swelling/ discoloration at vax site; tx=Keflex
Red left arm injection site 6" x 6" after 3rd shot/spreading/ about 6 inches long and wide/red at injection site; Swollen left arm injection site 6" x 6" after 3rd shot; Itching left arm injection site after 3rd shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red left arm injection site 6" x 6" after 3rd shot/spreading/ about 6 inches long and wide/red at injection site), VACCINATION SITE SWELLING (Swollen left arm injection site 6" x 6" after 3rd shot) and VACCINATION SITE PRURITUS (Itching left arm injection site after 3rd shot) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062E21A) for COVID-19 vaccination.     The patient's past medical history included Bipolar I disorder. Concomitant products included ARIPIPRAZOLE (ABILIFY) and MACROGOL 3350 (MIRALAX) for an unknown indication.    On 29-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Aug-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red left arm injection site 6" x 6" after 3rd shot/spreading/ about 6 inches long and wide/red at injection site), VACCINATION SITE SWELLING (Swollen left arm injection site 6" x 6" after 3rd shot) and VACCINATION SITE PRURITUS (Itching left arm injection site after 3rd shot). At the time of the report, VACCINATION SITE ERYTHEMA (Red left arm injection site 6" x 6" after 3rd shot/spreading/ about 6 inches long and wide/red at injection site), VACCINATION SITE SWELLING (Swollen left arm injection site 6" x 6" after 3rd shot) and VACCINATION SITE PRURITUS (Itching left arm injection site after 3rd shot) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment history was not reported.   This case was linked to MOD-2021-027468, MOD-2021-023570 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Sep-2021: Follow up report contains patient demographics, Relevent medical history and concomitant medication were added. On 01-Sep-2021: follow up report contains no new information(NNI)
BP 98/60 at time vaccines administered  After vaccines patient and mother stayed in the  room for 3 to 4 minutes, then walked out in hallway towards exit door but patient fell unconscious hit her head against edge of counter wall, had a 10 second seizure and within 30 seconds became alert and responsive, not sleepy or drowsy Pt was taken in wheelchair back to exam room laceration noted on scalp occipital area, gauze given to stop bleed. Pressure applied EMS 911 called and paramedics arrived 7 minutes later, BP 149/90 and taken to ER Pt is better still with staple stitches on scalp Per mom. To follow up here expected 7/23/2021
Information has been received from a parent on behalf of a female patient that was vaccinated with a varicella virus vaccine live (Oka/Merck). Concomitant vaccine administered included measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (+) varicella virus vaccine live (Oka/Merck) upgrade process). Three weeks ago, on approximately 25-JUL-2007, the patient developed a circular welt on her leg at the injection site and it is still there. At the time of this report, the patient is still not recovered. Unspecified medical attention was sought. No product quality complaint was involved. No further information was provided. No further information is available.
Worst vaginal yeast infection patient has ever experienced. Instead of feeling it coming on gradually, as is usual, it started very suddenly exactly 1 week after the first vaccination. The same thing happened after the 2nd vaccination, with exactly the same time frame (sudden onset of severe symptoms 1 week post-vaccine). Infection was more resistant to treatment than any vaginal yeast infection experienced in the past (probably about a dozen prior infections in lifetime). Required 2 rounds of oral medication of 3 doses each, plus a topical prescription cream.
On 9/17/21 client came in to vaccine site and complained that his right arm hurts at the vaccination site intermittently, several times a week, especially at the end of the day when driving.  He also states that beginning about a week after the vaccination that he has 4-5 dizzy spells a week.  He said that he did not have any of these symptoms before he was vaccinated.
Light headed, dizzy, nauseous, pins and needles in fingers, burning sensation at top of throat, difficulty swallowing - golf ball sensation on right side of throat, sensation up to right ear.
This case was reported by a pharmacist and described the occurrence of allergic reaction in a subject of unspecified age and gender who was vaccinated with Fluarix for prophylaxis. The subject's medical history included allergy to antibiotic. The subject had received influenza virus vaccine in previous years with no subsequent adverse events. On an unspecified date in 2006, on or before 14 November 2006, the subject received unspecified dose of Fluarix. On an unspecified date in 2006, on or before 14 November 2006, less than one year after vaccination with Fluarix the subject experienced allergic reaction and hive. The subject was seen in an emergency room. The outcome of the events was not reported.
p/vax pt swelling, redness & soreness in rt arm;palm of rt hand very red;pt took 3rd shot of anthrax;pt instructed to take ibuprofen & apply cold compress & seek medical consult @ allergist;results not available @ time of form completion;
Broke out with lesions the next day after Varicella immunization. No fever. No other symptoms. Benadryl, Calamine lotion, oatmeal bath.